Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 119
Selected: 0
NCT IDTitle
NCT04129281Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT06894823Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
NCT00401427HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
NCT07267780Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
NCT01802749Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
NCT00657878Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT05733793Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.
NCT06714357ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
NCT02624128Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
NCT02633189Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer
NCT01061619Pathway to Diagnosis of Ovarian Cancer
NCT01649674Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT02618850PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
NCT01644825Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer
NCT04595032MAnagement of METastatic Disease in Campania (MAMETIC)
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT01706120Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
NCT07290894Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
NCT02381054Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients
NCT00401492MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT06880523STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
NCT04310176Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
NCT06893861Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT01359956Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
NCT05818865"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT04139772Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
NCT07027046Application of da Vinci SP for Endometrial Cancer Surgical Staging
NCT05817227Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT00660842Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT07459920Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden
NCT01405573Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
NCT01628211Second Look Laparoscopy in Colorectal Cancer
NCT00996983Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer
NCT02035683PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT00403429MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
NCT06905145Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT04893356Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
NCT04854213PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
NCT03891485Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
NCT00412022HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
NCT06032975PRO for Fighting FT in Ovarian Cancer
NCT07302451REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
NCT00431704VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
NCT05733806Study on Gynecological Rare Cancers
NCT04290299Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive
NCT07522697Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4
NCT02069067Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
NCT06341764Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma